The supply of H1N1 vaccine is limited. Some places are only getting 1/4 of the total vaccine requested. Then a story comes out that Goldman Sachs found a way to pay for vaccines for their executives. I don't think very many Goldman execs are pregnant women or teenagers (highest risk groups) so something unethical is going on. THis article in the Wall Street Journal does a little investigative reporting to find out if the rich can get there hands on H1N1 vaccine. The verdict? Difficult but not impossible.
Very interesting read.
Omai